Investigating the use of Wearable Technologies as a Digital Biomarker for GBA1-Parkinson’s Disease
Objective: This study evaluates if wearable sensors can detect prodromal motor features in non-manifesting GBA1 variant carriers (GBA-NMC). It also investigates if GBA1-PD patients exhibit…Gathering Prodromal Participant Perspective on Receiving Personal Research Information
Objective: To understand perceptions and expectations of people with prodromal Parkinson’s disease (PD) around receiving personal research information. Background: There is limited information on the…Aspects of early detection of parkinson`s disease in ambulatory settings
Objective: Evaluation of the role and value of a special computer program for early detection of PD in ambulatory settings Background: The first symptoms of…Oculomotor changes in the premotor stage of LRRK2- G2019S associated Parkinson’s disease.
Objective: To analyse oculomotor differences among idiopathic PD patients (iPD), LRRK2-G2019S PD patients (LRRK2-G2019S PD), asymptomatic carriers of LRRK2-G2019S mutation (AsG2019S), and controls, evaluated by…Glial neurotrophic factor as an early diagnostic marker in Parkinson’s disease
Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) Background: Glial neutrophic factor (GDNF) is a…Alteration of the fecal microbiota in Turkish patients with idiopathic Parkinson’s disease
Objective: To determine whether the gut microbiota is altered in Turkish patients with Parkinson Disease (PD) and the potential effect of gut microbiota on pre-motor…Early predictors of Parkinson’s disease and prognosis in relatives
Objective: To study early clinical and biochemical markers of Parkinson's disease (PD) in relatives of Uzbek nationality. Background: Parkinson's disease is a neurodegenerative hereditary disease…Sick leaves in the years preceding the diagnosis of Parkinson’s disease: a nationwide case-control study in France
Objective: To examine whether the frequency of sick leaves is higher in patients with Parkinson’s disease (PD) than in controls in the years preceding diagnosis.…Application of the Movement Disorder Society Prodromal Criteria in healthy G2019S-LRRK2 carriers
Objective: To evaluate the MDS prodromal criteria in first-degree relatives of Ashkenazi Jewish G2019S-LRRK2 PD patients, who are considered a population at risk for developing…Differences of gut bacterial community relate to pathology progress in Parkinson’s disease
Objective: The aim of this study is to examine whether intestinal microbiota correlate with progression of clinical severity and serum inflammation marker. Background: Constipation is…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.